Fattorini L, Amicosante G, Fiorentino D, Franceschini N, Di Marzio L, Oratore A, Orefici G
Laboratory of Bacteriology and Medical Mycology, Istituto Superiore di Sanità, Rome, Italy.
J Chemother. 1989 Oct;1(5):293-7. doi: 10.1080/1120009x.1989.11738911.
The inhibiting or inactivating effects of some beta-lactam antibiotics on beta-lactamase from Mycobacterium fortuitum were studied. Among all substrates tested, clavulanic acid and sulbactam were the strongest competitive inhibitors of the enzyme although the latter was slightly hydrolyzed. Imipenem and cefoxitin scarcely inhibited the beta-lactamase yet expressed good activity against the microorganism in vitro, suggesting that the effectiveness of these drugs on M. fortuitum might be due to high permeation through the cell wall. All the isoxazolylpenicillins tested and methicillin inactivated the enzyme of M. fortuitum by a first rapid phase of acylation followed by a steady-state process of enzyme reactivation (deacylation). Clavulanic acid and sulbactam showed Ki values for the enzyme inactivation closely corresponding to hematic concentrations achievable in vivo during antibiotic treatment.
研究了某些β-内酰胺类抗生素对偶然分枝杆菌β-内酰胺酶的抑制或失活作用。在所有测试的底物中,克拉维酸和舒巴坦是该酶最强的竞争性抑制剂,尽管舒巴坦会被轻微水解。亚胺培南和头孢西丁几乎不抑制β-内酰胺酶,但在体外对该微生物表现出良好的活性,这表明这些药物对偶然分枝杆菌的有效性可能归因于其对细胞壁的高渗透性。所有测试的异恶唑基青霉素和甲氧西林通过酰化的第一个快速阶段使偶然分枝杆菌的酶失活,随后是酶再激活(脱酰化)的稳态过程。克拉维酸和舒巴坦对酶失活的Ki值与抗生素治疗期间体内可达到的血药浓度密切对应。